Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 3Phase 2 3Phase NA 2Phase 1/2 2Phase 2/3 1

Status

Completed 8Terminated 4Unknown 3Recruiting 2Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Sigmoidal Tumour 1Pain, Intractable 1Pain 1

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Morphine × Clear all
NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown
204 enrolled

Pain, Intractable

NCT01825993 2013-04-08

2013/004

Corporacion Parc Tauli

Phase 3 Unknown
225 enrolled

Sigmoidal Tumour

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡